Stay updated with breaking news from Mark Mcdade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) traded down 7.8% during trading on Tuesday . The stock traded as low as $38.61 and last traded at $39.33. 64,967 shares were traded during mid-day trading, a decline of 73% from the average session volume of 238,561 shares. The stock had previously closed at […]
“It’s hard work, it’s dirty work, but there’s always such a feeling of accomplishment at the end."
Icosavax (NASDAQ:ICVX – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “Icosavax Inc. is a biopharmaceutical company which focuses on life-threatening respiratory diseases. The company’s virus-like particle platform technology involved in developing vaccines against infectious […]
Icosavax (NASDAQ:ICVX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “Icosavax Inc. is a biopharmaceutical company which focuses on life-threatening respiratory diseases. The company’s virus-like particle platform technology involved in developing vaccines against infectious diseases. […]
Icosavax, Inc. (NASDAQ:ICVX – Get Rating) – William Blair dropped their Q2 2022 earnings estimates for Icosavax in a research note issued to investors on Tuesday, May 17th. William Blair analyst A. Hsieh now anticipates that the company will post earnings of ($0.60) per share for the quarter, down from their prior estimate of ($0.56). […]